High-mobility group box 1 as a predictive biomarker for drug-resistant epilepsy: A proof-of-concept study. (2022)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/epi.17116
PubMed Identifier: 34747496
Publication URI: http://europepmc.org/abstract/MED/34747496
Type: Journal Article/Review
Volume: 63
Parent Publication: Epilepsia
Issue: 1
ISSN: 0013-9580